Correlation Engine 2.0
Clear Search sequence regions

  • ags cell (1)
  • AKT (3)
  • akt protein (1)
  • apoptosis (2)
  • cell cycle (1)
  • cell growth (1)
  • dna mismatch repair (1)
  • e cadherin (1)
  • flow (1)
  • free (1)
  • gastric cancer (17)
  • gene (2)
  • humans (1)
  • kaplan meier (1)
  • metastasis (3)
  • mismatch repair (3)
  • MLH1 (1)
  • MSH2 (1)
  • MSH6 (1)
  • N cadherin (1)
  • paraffin (1)
  • patients (11)
  • PI3K (4)
  • PMS2 (1)
  • prognosis (10)
  • protein levels (1)
  • signal (1)
  • stomach neoplasms (1)
  • Thrombospondins (2)
  • TSP2 (22)
  • VEGF (3)
  • vimentin (1)
  • Sizes of these terms reflect their relevance to your search.

    This study aims to investigate thrombospondin 2 (TSP2) expression levels in gastric cancer (GC) and determine the relationship between TSP2 and clinical characteristics and prognosis. The online database Gene Expression Profile Interactive Analysis (GEPIA) was used to analyse TSP2 mRNA expression levels in GC. The Kaplan-Meier plotter prognostic analysis tool was used to evaluate the influence of TSP2 expression on clinical prognosis in GC patients. TSP2 expression levels were analysed in paraffin-embedded GC samples and adjacent normal tissues by immunohistochemistry. The relationship between the clinicopathological characteristics and prognosis of GC patients was assessed. Transwell experiments were used to evaluate the effect of TSP2 on HGC27 and AGS cell invasion and migration. The EdU experiment was used to detect the effect of transfection of TSP2 on cell proliferation, and the flow cytometry experiment was used to detect the effect of TSP2 on cell apoptosis and the cell growth cycle. Western blotting (Wb) technology was used to detect MMP, E-cadherin, N-cadherin, Vimentin, Snail, AKT, PI3K, and VEGF protein expression in HGC27 cells. Compared with normal tissues, TSP2 mRNA expression in GC was significantly upregulated and was closely related to the clinical stage of GC. High TSP2 expression significantly affected the OS, FP and PPS of patients with GC. Among these patients, TSP2 expression levels did not affect the prognosis of patients with GC in the N0 subgroup but significantly affected the prognosis of patients with GC in the N (1 + 2 + 3) subgroup. TSP2 protein expression levels were significantly higher in GC tissue compared with normal tissues (P < 0.01). The overall survival (OS) and relapse-free survival (RFS) of patients with high TSP2 expression were lower than those of patients with low TSP2 expression. Cells transfected with the TSP2-silencing sequence exhibited increased apoptosis and inhibition of proliferation, migration and invasion. AKT and PI3K expression in cells was significantly downregulated (P < 0.01). AKT, PI3K and VEGF expression in cells transfected with the TSP2 silencing sequence was significantly reduced. Proliferation, migration, invasion ability, and TSP2 expression levels significantly correlated with mismatch repair genes, such as PMS2, MSH6, MSH2, and MLH1 (P < 0.05). TSP2 expression is significantly increased in GC. TSP2 expression is closely related to metastasis and the mismatch repair process in GC patients and affects GC patient prognosis. The mechanism may involve regulating gastric cancer cell proliferation and migration by modulating the VEGF/PI3K/AKT signalling pathway. TSP2 is a potential marker and therapeutic target for the prognosis of GC patients. © 2022. The Author(s).


    Xiao-Dong Chu, Zheng-Bin Lin, Ting Huang, Hui Ding, Yi-Ran Zhang, Zhan Zhao, Shu-Chen Huangfu, Sheng-Hui Qiu, Yan-Guan Guo, Xiao-Li Chu, Jing-Hua Pan, Yun-Long Pan. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer. BMC cancer. 2022 Mar 07;22(1):250

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35255858

    View Full Text